Blood Purification
Original Paper
Peritoneal Dialysis as an Option for Unplanned Dialysis Initiation in Patients with End-Stage Renal Disease and Diabetes MellitusJin H. · Ni Z. · Che X. · Gu L. · Zhu M. · Yuan J. · Huang J. · Gu A. · Jin Y. · Yan H. · Wang Q. · Yu Z. · Zhou W. · Fang W.Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: August 11, 2017
Accepted: August 23, 2018
Published online: September 17, 2018
Issue release date: February 2019
Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 4
ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)
For additional information: https://www.karger.com/BPU
Abstract
Aims: This study aimed to compare the short-term complications and long-term prognosis between urgent-start peritoneal dialysis (PD) and hemodialysis (HD), and explore the safety and feasibility of PD in end-stage renal disease (ESRD) patients with diabetes. Methods: This retrospective study enrolled ESRD patients with diabetes who required urgent-start dialysis at a single center from January 2011 to December 2014. Short-term (30-day) dialysis-related complications and patient survival trends were compared between patients receiving PD and HD. Results: Eighty patients were included in the study, including 50 (62.5%) who underwent PD. The incidence of dialysis-related complications and complications requiring reinsertion during the first 30 days was significantly lower in PD patients. Logistic regression identified urgent-start HD as an independent risk factor for dialysis-related complications compared with urgent-start PD. The patient survival rate was higher in the PD compared to that in the HD group. Conclusions: PD may be acceptable, safe, and feasible for urgent-start dialysis in ESRD patients with diabetes.
© 2018 S. Karger AG, Basel
Related Articles:
References
-
Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al: Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet2015; 385: 1975–1982.
-
Zuo L, Wang M: Current burden and probable increasing incidence of ESRD in China. Clin Nephrol 2010; 74(suppl 1):S20–S22.
-
Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, et al: US Renal Data System. USRDS annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis 2011; 57: 1–526.
-
Machowska A, Alscher MD, Vanga SR, Koch M, Aarup M, Rutherford P: Offering patients therapy options in unplanned start: development and implementation of an education program for unplanned-start patients. Adv Perit Dial 2015; 31: 69–73.
-
Lok CE, Foley R: Vascular access morbidity and mortality: trends of the last decade. Clin J Am Soc Nephrol 2013; 8: 1213–1219.
-
Mendelssohn DC, Curtis B, Yeates K, Langlois S, MacRae JM, Semeniuk LM, et al: Suboptimal initiation of dialysis with and without early referral to a nephrologist. Nephrol Dial Transplant 2011; 26: 2959–2965.
-
Xue H, Ix JH, Wang W, Brunelli SM, Lazarus M, Hakim R, et al: Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications. Am J Kidney Dis 2013; 61: 123–130.
-
Moist LM, Trpeski L, Na Y, Lok CE: Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001–2004. Clin J Am Soc Nephrol 2008; 3: 1726–1732.
-
Mahnensmith RL: Urgent-start peritoneal dialysis: what are the problems and their solutions? Semin Dial 2014; 27: 291–294.
-
Povlsen JV, Ivarsen P: How to start the late referred ESRD patient urgently on chronic APD. Nephrol Dial Trans 2006; 21: 56–59.
-
Dias DB, Banin V, Mendes ML, Barretti P, Ponce D: Peritoneal dialysis can be an option for unplanned chronic dialysis: initial results from a developing country. Int Urol Nephrol 2016; 48: 901–906.
-
Wong LP, Li NC, Kansal S, Lacson E Jr, Maddux F, Kessler J, et al: Urgent peritoneal dialysis starts for ESRD: initial multicenter experiences in the United States. Am J Kidney Dis 2016; 68: 500–502.
-
See EJ, Cho Y, Hawley CM, Jaffrey LR, Johnson DW: Early and late patient outcomes in urgent-start peritoneal dialysis. Perit Dial Int 2017; 37: 414–419.
-
Nayak KS, Subhramanyam SV, Pavankumar N, Antony S, Sarfaraz Khan MA: Emergent start peritoneal dialysis for end-stage renal disease: outcomes and advantages. Blood Purif 2018; 45: 313–319.
-
Ghaderian SB, Hayati F, Shayanpour S, Beladi Mousavi SS: Diabetes and end-stage renal disease; a review article on new concepts. J Renal Inj Prev 2015; 4: 28–33.
-
Vonesh EF, Snyder JJ, Foley RN, Collins AJ: Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl 2006; 103:S3–S11.
-
Alkatheeri AM, Blake PG, Gray D, Jain AK: Success of urgent-start peritoneal dialysis in a large Canadian renal program. Perit Dial Int 2016; 36: 171–176.
-
Ghaffari A: Urgent-start peritoneal dialysis: a quality improvement report. Am J Kidney Dis 2012; 59: 400–408.
-
Koch M, Kohnle M, Trapp R, Haastert B, Rump LC, Aker S: Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis. Nephrol Dial Trans 2012; 27: 375–380.
-
Bitencourt Dias D, Mendes ML, Burgugi Banin V, Barretti P, Ponce D: Urgent-start peritoneal dialysis: the first year of Brazilian experience. Blood Purif 2017; 44: 283–287.
-
Liu Y, Zhang L, Lin A, Ni Z, Qian J, Fang W: Impact of break-in period on the short-term outcomes of patients started on peritoneal dialysis. Perit Dial Int 2014; 34: 49–56.
-
Jin H, Fang W, Zhu M, Yu Z, Fang Y, Yan H, et al: Urgent-start peritoneal dialysis and hemodialysis in ESRD patients: complications and outcomes. PLoS One 2016; 11: e0166181.
-
Jin H, Ni Z, Mou S, et al: Feasibility of urgent-start peritoneal dialysis in older patients with end-stage renal disease: a single-center experience. Perit Dial Int 2018; 38: 125–130.
-
Kim YL: What is the best dialysis therapy in developed and developing countries? peritoneal dialysis and/or hemodialysis: the trend in Korea. Contrib Nephrol 2017; 189: 65–70.
Article / Publication Details
Received: August 11, 2017
Accepted: August 23, 2018
Published online: September 17, 2018
Issue release date: February 2019
Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 4
ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)
For additional information: https://www.karger.com/BPU
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
